60.60
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
24.61%
745.34
|
598.12 | 657.29 | 625.71 | 629.69 |
Cost Of Revenue |
27.31%
248.76
|
195.40 | 263.44 | 270.51 | 260.04 |
Gross Profit |
23.30%
496.58
|
402.72 | 393.86 | 355.19 | 369.65 |
|
37.53%
420.47
|
305.72 | 333.58 | 307.09 | 320.03 |
Benefits Costs and Expenses |
12.68%
557.17
|
494.45 | 632.63 | 568.67 | 582.11 |
Costs And Expenses |
12.68%
557.17
|
494.45 | 632.63 | 568.67 | 582.11 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
21.54%
76.11
|
97.00 | 60.27 | 48.10 | 49.62 |
Net Interest Income/Expense |
58.77%
0.693
|
1.681 | 0.815 | -0.775 | -2.335 |
Nonoperating Income/Loss |
1,582%
112.06
|
6.664 | -35.61 | 8.934 | - |
Income/Loss From Continuing Operations Before Tax |
81.52%
188.17
|
103.67 | 24.67 | 57.03 | 47.58 |
Income Tax Expense/Benefit |
152.02%
-14.67
|
28.21 | -1.838 | 5.196 | 15.82 |
Income/Loss From Continuing Operations After Tax |
168.81%
202.85
|
75.46 | 26.50 | 51.84 | 31.76 |
|
168.81%
202.85
|
75.46 | 26.50 | 51.84 | 31.76 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.13%
135.21
|
136.76 | 0.336 | 135.62 | 135.19 |
Diluted Average Shares |
2.34%
136.50
|
139.77 | 0.618 | 138.06 | 136.98 |
Basic Earnings Per Share |
172.73%
1.50
|
0.55 | 0.20 | 0.38 | 0.23 |
Diluted Earnings Per Share |
175.93%
1.49
|
0.54 | 0.19 | 0.38 | 0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):